tel: (646)-791-2397 info@synergycap1.com
  • Facebook
  • Twitter
  • Facebook
  • Twitter
Synergy Capital
  • Business Financing
  • Careers
  • Partner
  • Apply
  • About Us
  • Contact Us
  • Synergy Capital
  • News
Select Page

Return of oil’s ‘risk premium’ hinges on Syria allies Russia and Iran

by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

The response of Russia and Iran to U.S. missile strikes on Syria will be a crucial determinant of whether the “risk premium” returns to benchmark oil prices, commodity strategists and economists told CNBC. Crude oil futures jumped by as much as 2 percent...

EU regulators to approve Fox takeover of Sky: sources

by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

Rupert Murdoch, executive chairman of News Corporation, reacts during a panel discussion at the B20 meeting of company CEOs in Sydney, July 17, 2014. REUTERS/Jason Reed/File Photo

Creating Insatiable Content Starts with Passion

by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Marketing, Working Capital

Not to date myself or anything, but I vividly remember being a marketer before Google Adwords, marketing automation, and advanced data. Interesting times, to say the least. What stands out in particular is a conversation I had with a sales rep about buying billboard...

Global Bonds: Bears and Bulls Fight Over Scraps

by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Business Lending, Business Loans, Capital, Finance, Non-Bank Loans, Working Capital

Bonds unsurprisingly gained as news of the U.S. strike on Syria emerged. But the longer-term outlook points to disappointing returns.

Global Bonds: Bears and Bulls Fight Over Scraps

by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Business Lending, Business Loans, Capital, Finance, Non-Bank Loans, Working Capital

Bonds unsurprisingly gained as news of the U.S. strike on Syria emerged. But the longer-term outlook points to disappointing returns.

The Cost of Drugs for Rare Diseases Is Threatening the U.S. Health Care System

by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital

Executive Summary Biogen’s pricing of Spinraza, a new drug for treating infants with spinal muscular atrophy (SMA), signals a larger threat to the U.S. health care system: the cumulative cost of therapies for rare diseases may be impossible to bear. Five days...
« Older Entries
Next Entries »
Copyright © 2016 Synergy Capital. All rights reserved.